Q&A: RSV's hidden toll—adults of all ages may struggle with breathlessness, daily activities for months
Recovering from respiratory syncytial virus often doesn't end when it's time to leave the hospital, even for younger adults.
Dec 9, 2025
0
16
MeSH tree: B04.820.480.937.600.670
Recovering from respiratory syncytial virus often doesn't end when it's time to leave the hospital, even for younger adults.
Dec 9, 2025
0
16
An infection with respiratory syncytial virus (RSV) typically affects infants much harder than adults. While adults usually experience RSV as a mild cold, infants can develop more severe conditions, including life-threatening ...
Dec 9, 2025
0
13
A vaccine against a widespread virus has prevented the admission to hospital of more than 200 babies in Scotland, according to new research.
Dec 3, 2025
0
20
Belgian scientists from VIB and Ghent University (UGent), together with Danish collaborators, have uncovered compelling evidence that early-infancy infection with respiratory syncytial virus (RSV) significantly increases ...
Nov 28, 2025
0
42
Providing year-round access to RSV immunization would minimize the risk of large seasonal outbreaks across the nation, including in both urban and rural areas.
Nov 26, 2025
0
21
In two experiments, researchers have found that introducing people to "mental models" about how mRNA vaccination works and how the body protects itself from foreign DNA can preemptively or reactively protect against misconceptions ...
Nov 24, 2025
0
43
Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the respiratory virus season. However, especially among young infants under six months of age or people ...
Nov 13, 2025
0
29
As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid scientific advice for policymakers and public health authorities on ways to mitigate the impact of RSV ...
Nov 13, 2025
0
10
Often confused for a common cold, respiratory syncytial virus (RSV) can in fact be serious and should be studied more closely. In studies led by Singapore General Hospital (SGH), researchers collaborating under the Program ...
Nov 6, 2025
0
34
Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according to a multi-institutional ...
Nov 6, 2025
0
34